Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Trajectory of intensive treat-to-target disease modifying drug regimen in an observational study of an early rheumatoid arthritis cohort.

White D, Pahau H, Duggan E, Paul S, Thomas R.

BMJ Open. 2013 Jul 31;3(7). pii: e003083. doi: 10.1136/bmjopen-2013-003083.

2.

The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses.

Aletaha D, Smolen JS.

Rheumatology (Oxford). 2002 Dec;41(12):1367-74.

PMID:
12468815
3.

[Disease-modifying treatment for inflammatory rheumatism in sub-Saharan Africa: outcome at 6 months of 205 Senegalese patients with rheumatoid arthritis].

Ndongo S, Pouye A, Lekpa FK, Bihéhé DM, Tiendrebeogo J, Ndao AC, Ka MM, Moreira Diop T.

Med Sante Trop. 2012 Oct-Dec;22(4):385-9. doi: 10.1684/mst.2012.0096. French.

4.

Comparison of the baseline disease activity of early oligo- and polyarthritis in sequential years.

Jansen LM, van der Horst-Bruinsma IE, van Schaardenburg D, Lard LR, Hazes JM, Huizinga TW, Dijkmans BA.

Clin Exp Rheumatol. 2004 Jul-Aug;22(4):447-52.

PMID:
15301242
5.

Databases of patients with early rheumatoid arthritis in the USA.

Sokka T, Willoughby J, Yazici Y, Pincus T.

Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S146-53. Review.

PMID:
14969067
6.

Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three years.

Wabe N, Sorich MJ, Wechalekar MD, Cleland LG, McWilliams L, Lee A, Spargo L, Metcalf RG, Hall C, Proudman SM, Wiese MD.

Arthritis Res Ther. 2015 Mar 8;17:48. doi: 10.1186/s13075-015-0562-0.

7.

Outcome of patients with rheumatoid arthritis: cross-sectional study of a single-center real-world inception cohort.

Ling E, Ofer-Shiber S, Goren O, Molad Y.

Isr Med Assoc J. 2013 Dec;15(12):758-62.

9.

Treat-to-target approach in daily clinical practice in Pakistani patients with early Rheumatoid Arthritis.

Farman S, Ahmad NM, Saeed MA, Asad K, Shabbir G.

J Coll Physicians Surg Pak. 2015 Feb;25(2):129-33. doi: 02.2015/JCPSP.129133.

PMID:
25703758
10.

Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study.

Innala L, Berglin E, Möller B, Ljung L, Smedby T, Södergren A, Magnusson S, Rantapää-Dahlqvist S, Wållberg-Jonsson S.

Arthritis Res Ther. 2014 Apr 14;16(2):R94. doi: 10.1186/ar4540.

11.

Outcome of rheumatoid arthritis following adjunct statin therapy.

Das S, Mohanty M, Padhan P.

Indian J Pharmacol. 2015 Nov-Dec;47(6):605-9. doi: 10.4103/0253-7613.169585.

12.

Summary of AHRQ's comparative effectiveness review of drug therapy for rheumatoid arthritis (RA) in adults--an update.

Singh JA, Cameron DR.

J Manag Care Pharm. 2012 May;18(4 Supp C):S1-18. Review.

PMID:
22656072
13.

Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use.

Proudman SM, James MJ, Spargo LD, Metcalf RG, Sullivan TR, Rischmueller M, Flabouris K, Wechalekar MD, Lee AT, Cleland LG.

Ann Rheum Dis. 2015 Jan;74(1):89-95. doi: 10.1136/annrheumdis-2013-204145. Epub 2013 Sep 30.

PMID:
24081439
15.

Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.

Proudman SM, Keen HI, Stamp LK, Lee AT, Goldblatt F, Ayres OC, Rischmueller M, James MJ, Hill CL, Caughey GE, Cleland LG.

Semin Arthritis Rheum. 2007 Oct;37(2):99-111. Epub 2007 Mar 27.

PMID:
17391739
16.

Prognostic markers of clinical remission in early rheumatoid arthritis after two years of DMARDs in a clinical setting.

Vázquez I, Graell E, Gratacós J, Cañete JD, Viñas O, Ercilla MG, Gómez A, Hernández MV, Rodríguez-Cros JR, Larrosa M, Sanmartí R.

Clin Exp Rheumatol. 2007 Mar-Apr;25(2):231-8.

PMID:
17543147
17.

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.

Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. Review.

18.
19.

Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs.

Sizova L.

Br J Clin Pharmacol. 2008 Aug;66(2):173-8. doi: 10.1111/j.1365-2125.2008.03222.x. Epub 2008 May 15. Review.

20.

Initial combination therapy versus step-up therapy in treatment to the target of remission in daily clinical practice in early rheumatoid arthritis patients: results from the DREAM registry.

Steunebrink LM, Versteeg GA, Vonkeman HE, Ten Klooster PM, Kuper HH, Zijlstra TR, van Riel PL, van de Laar MA.

Arthritis Res Ther. 2016 Mar 8;18:60. doi: 10.1186/s13075-016-0962-9.

Supplemental Content

Support Center